Home
News
Create
Screeners
Insights
Trualt Bioenergy
434.
85
-1.90
(-0.44%)
Market Cap
₹3,728.95 Cr
PE Ratio
25.33
Industry
FMCG
Buy
Sell
Company Performance:
1D
-0.44%
1M
+14.81%
6M
-18.10%
1Y
-18.10%
5Y
-18.10%
View Company Insights
Latest news about Trualt Bioenergy
TruAlt Bioenergy Utilizes Rs 519.63 Crore of IPO Proceeds in Q3FY26, Reports No Deviations
2 days ago
TruAlt Bioenergy Limited utilized Rs 519.63 crore of its Rs 750.00 crore IPO proceeds during Q3FY26, with monitoring agency Crisil Ratings confirming no deviations from stated objectives. The company deployed funds across capital expenditure (Rs 140.13 crore), working capital (Rs 263.22 crore), and general corporate purposes (Rs 69.99 crore), while maintaining Rs 230.37 crore in term deposits and bank accounts earning 5.00% returns.
TruAlt Bioenergy Q3FY26: 72% Revenue Growth with Full Operational Scale Achievement
9 days ago
TruAlt Bioenergy Limited Appoints Mr. Monu Kumar as Interim Company Secretary and Compliance Officer
Jan 09, 2026
TruAlt Bioenergy Reports Strategic Revenue Decline, Eyes Strong Recovery with Multi-Feed Operations
Nov 19, 2025
TruAlt Bioenergy Reports Q2 Loss Amid Transition to Year-Round Operations
Nov 12, 2025
More news about Trualt Bioenergy
11
Nov 25
Trualt Bioenergy Forges Strategic Partnership with Sumitomo Corp for CBG Plant Development
Trualt Bioenergy Limited (TBL) has formed a strategic partnership with Japan's Sumitomo Corporation to develop and scale commercial compressed biogas (CBG) plants in India. TBL will hold 51% stake in Trualt Gas Private Limited (TGPL), while Sumitomo acquires 49%. The joint venture aims to set up biogas and CBG production facilities, focusing initially on four plants. This collaboration is expected to promote clean energy solutions, reduce carbon footprint, and advance India's circular bioeconomy. TBL recently completed an oversubscribed IPO, raising approximately Rs. 750.00 crore. The company is also in talks for an Ethanol to Sustainable Aviation Fuel plant in Andhra Pradesh and has an agreement with GAIL for potential investment in its subsidiary.
28
Oct 25
Trualt Bioenergy Approves Rs 180 Crore Corporate Guarantee and Rs 20 Crore Investment in Subsidiary
Trualt Bioenergy Limited has approved a corporate guarantee for 51% of a Rs 180 crore NABARD loan to its subsidiary, Trualt Gas Private Limited (TGPL), for three CBG plants. The company will invest an additional Rs 20 crore in TGPL's equity shares at Rs 24 per share. This aligns with a joint venture agreement with Sumitomo Corporation, where Trualt holds 51% and Sumitomo 49%. The board also removed Deepak Kumar Gulati as Company Secretary due to prolonged absence and unsatisfactory performance.
22
Oct 25
Trualt Bioenergy Approves Q1 Results and ₹84.21 Crore Stake Acquisition in Trualt Gas
Trualt Bioenergy Limited's board has approved unaudited Q1 financial results and the acquisition of a 51% stake in Trualt Gas Private Limited for ₹84.21 crore. The acquisition involves purchasing 35.08 lakh equity shares at ₹24 per share from Nirani Holdings Private Limited, a promoter group company. Trualt Gas, incorporated in September 2024, operates in the compressed biogas sector but hasn't started commercial operations yet. This move aligns with Trualt Bioenergy's growth strategy in the CBG market and aims to facilitate a proposed joint venture with SUMITOMO Corporation in the biogas business.
19
Oct 25
Trualt Bioenergy Approves Q1 FY2026 Results and Strategic Acquisition in Compressed Biogas Sector
Trualt Bioenergy Limited's Board has approved the acquisition of a 51% stake in Trualt Gas Private Limited (TGPL) for Rs. 8.42 crore. TGPL, incorporated in 2024, will focus on compressed biogas production from municipal waste and press mud. The acquisition aligns with Trualt's strategy to expand in renewable energy and supports a proposed joint venture with SUMITOMO Corporation. The Board also approved Q1 FY2026 financial results. The deal is expected to complete by November 30, 2025.
06
Oct 25
TruAlt Bioenergy Shares Slip 6.7% Post-Listing Amid Valuation Concerns
TruAlt Bioenergy's stock price has fallen 6.70% from its listing price of Rs 550.00 to Rs 513.10 within two trading sessions after its IPO. The decline comes despite strong financial results, with revenue up 54% to Rs 1,969.00 crore and net profit increasing nearly five-fold to Rs 147.00 crore. Analysts cite concerns over aggressive valuation compared to industry peers, with the company trading at 29 times earnings. Market sentiment remains mixed, with some recommending partial profit booking while others highlight the company's diversified portfolio in India's renewable energy sector.
Trualt Bioenergy
434.
85
-
1.
90
(-
0.
44
%)
1 Year Returns:
-18.10%
Industry Peers
LT Foods
428.85
(+
1.
64
%)
KRBL
371.55
(+
0.
05
%)
Gujarat Ambuja Exports
138.32
(+
2.
64
%)
Kaveri Seed Company
902.85
(+
1.
09
%)
Trualt Bioenergy
434.85
(-
0.
44
%)
GRM Overseas
162.83
(+
0.
17
%)
Sanstar
90.27
(-
0.
35
%)
Chaman Lal Setia Exports
274.78
(+
1.
33
%)
Avt Natural Products
66.97
(-
0.
58
%)
Gulshan Polyols
162.87
(-
0.
51
%)
Get More Market Insights with
Heatmap
FII/DII
Company Filings
MF Holdings
Bulk/Block Deals
Stock Rental via SLBM
Signals
MTF Insights
F&O Ban - MWPL
Top Deliveries
Market Valuation